Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Favorable trial results with interferon gamma-1b for atopic dermatitis and keloids

June 7, 1996

Collagen Corp. acquires distribution rights to Tissue Technologies' ePTFE implant

June 7, 1996

Synthetic retinoid analogue cleared for U.S. market

June 7, 1996

Oclassen obtains rights to 5-MOP

June 7, 1996

Retinoid antagonists revealed by Eisai

May 31, 1996

Efficacy of Peptide Technology's oral psoriasis treatment confirmed

May 31, 1996

Amlexanox approvable in U.S.

May 24, 1996

Propecia NDA filing slated for late 1996

May 24, 1996

Wound-healing peptides claimed by Morinaga Milk

May 24, 1996

ALA PDT results outstanding in patients with precancerous actinic keratoses

May 17, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...